Misiu143, I have been impressed by leronlimab s
Post# of 148169
(Total Views: 629)
Posted On: 08/27/2020 7:16:12 PM
Misiu143,
I have been impressed by leronlimab since I learned of it in context of Covid. Further investigation has caused my jaw to drop.
Kudos “long”‘longs for recognizing the significance of leronlimab years ago.
My colleague and friend, who is an ER doctor, has drawn a blank when I’ve asked repeatedly what we are missing and where the holes may be in the Covid as MOA as articulated by Patterson (much less HIV and the Ohm20 master list).
The only criticisms we have been able to mount, as many have here, are the challenges of navigating the regulatory approval process with a talented, but in this sphere, relatively inexperienced management team while parrying attacks from BP and their minions.
Dr. pourhassan et al have performed remarkably well. Many may, but I cannot bring myself to criticize the achievements of Cytodyn and the cusp of success to which we have been led.
Great success and a return to “normal times” lie ahead.
Be well.
I have been impressed by leronlimab since I learned of it in context of Covid. Further investigation has caused my jaw to drop.
Kudos “long”‘longs for recognizing the significance of leronlimab years ago.
My colleague and friend, who is an ER doctor, has drawn a blank when I’ve asked repeatedly what we are missing and where the holes may be in the Covid as MOA as articulated by Patterson (much less HIV and the Ohm20 master list).
The only criticisms we have been able to mount, as many have here, are the challenges of navigating the regulatory approval process with a talented, but in this sphere, relatively inexperienced management team while parrying attacks from BP and their minions.
Dr. pourhassan et al have performed remarkably well. Many may, but I cannot bring myself to criticize the achievements of Cytodyn and the cusp of success to which we have been led.
Great success and a return to “normal times” lie ahead.
Be well.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼